General Information of the Compound
Compound ID
CP0579952
Compound Name
5-chloro-4-[4-oxo-3-[[2-(trifluoromethyl)phenyl]methyl]imidazolidin-1-yl]-1H-pyridazin-6-one
    Show/Hide
Structure
Formula
C15H12ClF3N4O2
Molecular Weight
372.734
Canonical SMILES
FC(F)(F)c1ccccc1CN1CN(CC1=O)c1cn[nH]c(=O)c1Cl
    Show/Hide
InChI
InChI=1S/C15H12ClF3N4O2/c16-13-11(5-20-21-14(13)25)22-7-12(24)23(8-22)6-9-3-1-2-4-10(9)15(17,18)19/h1-5H,6-8H2,(H,21,25)
    Show/Hide
InChIKey
XDKALEWAXRMGQR-UHFFFAOYSA-N
Physicochemical Property
logP
2.2484
Rotatable Bonds
3
Heavy Atom Count
25
Polar Areas
69.3
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 168296450
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT05452, Short transient receptor potential channel 5
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS